Cited by 9Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeurological Disorders and Treatments

Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro

Mattii, Letizia, Pardini, Carla, Ippolito, Chiara, Bianchi, Francesco, Sabbatini, Antonietta Raffaella Maria, Vaglini, Francesca·2019·NeuroToxicology

Abstract

Mesencephalic cell cultures are a good model to study the vulnerability of dopaminergic neurons and reproduce, in vitro, experimental models of Parkinson's disease. Rotenone associated as an environmental neurotoxin related to PD, is able to provoke dopaminergic neuron degeneration by inhibiting complex I of the mitochondrial respiratory chain and by inducing accumulation of α-synuclein. Recently, rotenone has been described to activate RhoA, a GTPase protein. In the present study we evaluated a possible neuroprotective effect of Rho-inhibitor molecules on rotenone-damaged dopaminergic (DA) neurons obtained from mouse primary mesencephalic cell culture. Our results showed that Clostridium Botulinum C3 toxin (C3) and simvastatin, as RhoA inhibitors, were able to protect DA neurons from rotenone damages. In fact, pretreatment with C3 or simvastatin significantly prevented the reduction of [ 3 H]dopamine uptake, neurites injury and the expression patterns of proteins like α-syn, actin and connexin 43.

Integrity signals

Registry

Crossref · 10.1016/j.neuro.2019.02.006

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rotenone treatment of primary mouse mesencephalic cultures increases RhoA activity, and RhoA inhibition using either C3 transferase or Simvastatin protects dopaminergic neurons against rotenone-induced neurite damage.

    “Similarly, rotenone treatment of primary mouse mesencephalic cultures increased RhoA activity, and RhoA inhibition using either C3 transferase or Simvastatin protected the dopaminergic neurons against rotenone-induced neurite damage [177].”

    From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [177]

Cited by

Sorted by citations

Authors
Mattii, L., Pardini, C., Ippolito, C., Bianchi, F., Sabbatini, A. R. M., & Vaglini, F.
Affiliations
University of Pisa (IT)
Corresponding author
Vaglini, Francesca
Venue
NeuroToxicology
Publisher
Elsevier BV
Published
2019-05
Volume
72
Pages
51-60
ISSN
0161-813X (ISSN-L)
OpenAlex
W2913237658
Cited by
9
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Locations
  • NeuroToxicology (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Funders
PRA “Progetti di Ricerca di Ateneo” from the University of Pisa
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
RhoA inhibition, rotenone, dopaminergic neurons, Parkinson's disease, neuroprotection, simvastatin, mitochondrial complex I inhibition, alpha-synuclein, dopamine uptake, connexin 43, actin
MeSH terms
Animals, Botulinum Toxins, Cells, Cultured, Rotenone, Neuroprotective Agents, Simvastatin, rhoA GTP-Binding Protein, Mice, Dopaminergic Neurons, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review